SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus Announces Second Quarter 2024 Financial Results

06 أغسطس 2024 16:06:00 بحسب Nasdaq GlobeNewswire

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

01 أغسطس 2024 16:30:11 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

23 يوليو 2024 16:13:37 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

30 مايو 2024 16:25:33 بحسب Nasdaq GlobeNewswire

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

23 مايو 2024 16:05:48 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

09 مايو 2024 16:05:39 بحسب Nasdaq GlobeNewswire

Supernus Announces First Quarter 2024 Financial Results

08 مايو 2024 16:05:50 بحسب Nasdaq GlobeNewswire

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

01 مايو 2024 08:00:32 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

24 أبريل 2024 16:05:53 بحسب Nasdaq GlobeNewswire

Supernus Provides Regulatory Update for SPN-830

08 أبريل 2024 08:00:16 بحسب Nasdaq GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences

06 مارس 2024 16:30:50 بحسب Nasdaq GlobeNewswire

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

28 فبراير 2024 16:30:04 بحسب Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

27 فبراير 2024 16:05:33 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

13 فبراير 2024 16:05:20 بحسب Nasdaq GlobeNewswire

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

05 فبراير 2024 08:30:39 بحسب Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2023 Financial Results

08 نوفمبر 2023 16:05:44 بحسب Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies London Healthcare Conference

07 نوفمبر 2023 16:30:42 بحسب Nasdaq GlobeNewswire

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

02 نوفمبر 2023 07:00:05 بحسب Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023

25 أكتوبر 2023 16:15:32 بحسب Nasdaq GlobeNewswire

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey

16 أكتوبر 2023 17:34:21 بحسب Nasdaq GlobeNewswire